MMADHC

MMADHC (CblD) is a cobalamin trafficking chaperone that operates at the branch point of intracellular vitamin B12 metabolism, partitioning the cofactor between cytosolic methylcobalamin synthesis for methionine synthase and mitochondrial adenosylcobalamin synthesis for methylmalonyl-CoA mutase (PMID:15292234, PMID:22156578). Its structured C-terminal domain adopts a nitroreductase fold that mediates a 1:1 interaction with MMACHC (CblC)-bound cob(II)alamin, forming an interprotein thiolato-cobalt complex through which the cofactor is transferred downstream, while the disordered N-terminal region harbors the mitochondrial targeting sequence required for adenosylcobalamin production (PMID:26483544, PMID:26364851, PMID:35589192). MMADHC is dually localized to the cytoplasm and mitochondria; its cytosolic abundance is regulated by mitochondrial membrane potential, linking mitochondrial status to methionine synthase activity and one-carbon metabolism (PMID:23270877, PMID:41509439). Biallelic loss-of-function mutations in MMADHC cause the cblD defect of vitamin B12 metabolism, manifesting as isolated methylmalonic aciduria, isolated homocystinuria, or combined disease depending on whether mutations disrupt the N-terminal or C-terminal functional domain (PMID:18385497, PMID:19058814).

1. 2004 High

   Complementation analysis revealed that a single genetic locus (cblD) can produce three distinct biochemical phenotypes—isolated homocystinuria, isolated methylmalonic aciduria, or combined deficiency—establishing that the cblD gene product acts at a branch point directing cobalamin to both cytosolic and mitochondrial pathways.

   Evidence Complementation analysis and cobalamin derivative synthesis assays in multiple patient fibroblast lines

   PMID:15292234

   Open questions at the time

   • Gene identity not yet determined
   • Mechanism of branch-point decision unknown
2. 2008 High

   Positional cloning identified MMADHC as the cblD gene, and wild-type cDNA rescued both adenosylcobalamin and methylcobalamin synthesis in patient cells, while genotype–phenotype correlations showed that N-terminal mutations cause methylmalonic aciduria and C-terminal mutations cause homocystinuria, revealing domain-specific functions.

   Evidence Microcell-mediated chromosome transfer, genetic mapping, transfection rescue in patient fibroblasts, and mutation analysis across multiple cblD patients

   PMID:18385497 PMID:19058814

   Open questions at the time

   • Whether MMADHC binds cobalamin directly was unknown
   • Structural basis for domain-specific functions unresolved
3. 2010 High

   The demonstration that MMADHC physically interacts with MMACHC via multiple binding sites, confirmed by orthogonal methods, established MMADHC as a direct downstream partner of the CblC processing enzyme rather than an independent cobalamin-binding protein.

   Evidence Phage display, surface plasmon resonance, and bacterial two-hybrid assays with recombinant proteins

   PMID:21071249

   Open questions at the time

   • Cobalamin-dependence of the interaction not yet tested
   • Stoichiometry of the complex unresolved
4. 2011 High

   Systematic domain-swapping experiments defined Met116 as the boundary: sequence downstream of Met116 suffices for methylcobalamin synthesis, while the region between Met62 and Met116 is additionally required for adenosylcobalamin production, with enhanced mitochondrial targeting increasing AdoCbl at the expense of MeCbl—directly demonstrating MMADHC as the branch-point regulator.

   Evidence Transfection of modified MMADHC constructs with altered mitochondrial leader sequences and downstream reinitiation sites into patient fibroblasts, with quantitative AdoCbl/MeCbl synthesis assays

   PMID:22156578

   Open questions at the time

   • How subcellular partitioning is regulated physiologically was unknown
   • Whether reinitiation of translation at Met116 is a general mechanism in vivo was unclear
5. 2012 High

   Biophysical characterization showed MMADHC is a monomer with a disordered N-terminal domain and a structured C-terminal domain that mediates MMACHC binding with sub-micromolar affinity, and importantly that MMADHC does not bind cobalamin directly, confirming it functions as an adaptor rather than a carrier.

   Evidence Recombinant protein purification, dynamic light scattering, circular dichroism, clear-native PAGE, SPR; dual localization confirmed by immunofluorescence and subcellular fractionation

   PMID:22832074 PMID:23270877

   Open questions at the time

   • Atomic-resolution structure not yet available
   • How cobalamin is transferred from MMACHC through MMADHC to downstream enzymes unresolved
6. 2013 High

   Isolation of the MMACHC–MMADHC complex under defined cobalamin conditions showed that complex formation is favored after MMACHC-mediated dealkylation, establishing that MMADHC acts downstream of the CblC processing step and receives already-dealkylated cobalamin.

   Evidence Complex isolation under defined cobalamin substrate conditions, limited proteolysis, fibroblast dealkylation assays

   PMID:23415655

   Open questions at the time

   • Fate of cofactor after MMADHC interaction still unresolved
   • Molecular basis for preferential complex formation with dealkylated cobalamin unclear
7. 2014 High

   Fine-resolution mutagenesis mapped the MeCbl-specific function to residues ~R197–D226 and showed that progressive C-terminal truncations shift the phenotype from isolated homocystinuria to combined MMA/HC deficiency, defining precise domain boundaries for cytoplasmic cobalamin trafficking.

   Evidence 15 missense and 5 C-terminal truncation constructs tested by transfection rescue in immortalized cblD fibroblasts

   PMID:24722857

   Open questions at the time

   • No structural interpretation of how these residues participate in MeCbl-specific function
   • Residues required for mitochondrial AdoCbl function not systematically mapped at this resolution
8. 2015 High

   Crystal structures of the MMADHC C-terminal domain revealed a nitroreductase fold homologous to MMACHC despite negligible sequence similarity, and SAXS confirmed a 1:1 heterodimer with MMACHC where the interaction surface overlaps the cobalamin-binding site; kinetic assays showed CblD enhances oxidation of CblC-bound cob(II)alamin, with disease mutations impairing this reaction.

   Evidence X-ray crystallography at 2.2 Å resolution, SAXS, mutagenesis of disease-causing variants, kinetic assays for cob(II)alamin oxidation

   PMID:26364851 PMID:26483544

   Open questions at the time

   • No structure of the full-length MMADHC including the disordered N-terminal domain
   • Structural basis for how cobalamin is handed off to methionine synthase or mitochondrial pathway unknown
9. 2016 Medium

   Co-immunoprecipitation and proximity ligation assays identified MMADHC as part of a cytoplasmic multiprotein complex with methionine synthase, methionine synthase reductase, and MMACHC, suggesting a channeling mechanism for cobalamin delivery to methionine synthase.

   Evidence Co-IP and DuoLink proximity ligation in patient fibroblasts and HepG2 cells with siRNA knockdown

   PMID:27771510

   Open questions at the time

   • Interaction with MS/MSR not independently replicated
   • Stoichiometry and architecture of the multiprotein complex unresolved
   • Whether the complex is constitutive or regulated is unknown
10. 2022 Medium

    Biochemical characterization confirmed that MMADHC forms an interprotein thiolato-cobalt coordination complex with MMACHC-bound cob(II)alamin and can transfer the cofactor to methionine synthase, establishing the chemical nature of the hand-off intermediate.

    Evidence Enzymatic assays characterizing chaperone activities of the CblC–CblD complex

    PMID:35589192

    Open questions at the time

    • Precise mechanism of cofactor transfer to methionine synthase not elucidated
    • Whether a similar coordination complex forms during mitochondrial AdoCbl delivery is unknown
11. 2025 Medium

    Proteomic and functional studies showed that mitochondrial membrane potential collapse stabilizes MMADHC in the cytosol (due to import failure), which in turn increases methionine synthase protein levels and activity—revealing MMADHC as a sensor linking mitochondrial status to cytosolic one-carbon metabolism. Separately, cryo-EM structures of apo methionine synthase showed MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading.

    Evidence Joint proteomic/RNA-seq screen, subcellular fractionation, PMF collapse experiments, MTR activity assays (preprint); cryo-EM of MTR with AlphaFold-guided interaction mapping (preprint)

    PMID:41509439 PMID:bio_10.1101_2025.11.10.687659

    Open questions at the time

    • Both studies are preprints awaiting peer review
    • Structural details of MMADHC–apo MTR interface require experimental validation beyond AlphaFold
    • Whether MMADHC sensing of mitochondrial status is relevant in vivo under physiological stress is untested

• The mechanism by which MMADHC partitions cobalamin between the mitochondrial adenosylcobalamin and cytosolic methylcobalamin pathways—including the signals governing this decision, the structural basis for cofactor hand-off to methionine synthase and to the mitochondrial import machinery, and the physiological regulation of MMADHC partitioning in vivo—remains incompletely understood.
• No structure of full-length MMADHC or its complex with a downstream target
• Mechanism of cobalamin transfer to methylmalonyl-CoA mutase in mitochondria uncharacterized
• In vivo regulation of the branch-point decision is unknown